skip to main content
10.1145/3469678.3469716acmotherconferencesArticle/Chapter ViewAbstractPublication PagesbibeConference Proceedingsconference-collections
research-article

Analysis of Risk Factors for Hyperglycemia and GHR Gene Polymorphism in Growth Hormone secreting Pituitary Adenoma

Authors Info & Claims
Published:28 July 2021Publication History

ABSTRACT

First, to analyze the risk factors of hyperglycemia in Growth hormone-secreting pituitary adenoma(GHPA) by comparing clinical data, biochemical indexes, and imaging data. Second, to study the correlation between growth hormone receptor (GHR) gene polymorphism and hyperglycemia. The results of this study will help to evaluate the GHPA condition and choose effective treatment measures, reduce the GHPA clinical mortality and improve the prognosis of GHPA. From January 2014 to July 2020, we collected 120 patients 18-75 years old who were diagnosed with GHPA in the First Affiliated Hospital of Kunming Medical University. According to blood glucose levels, they were divided into hyperglycemia as the study group and normal blood glucose as a control group. The course of the disease, BMI, FPG, GH, HOMA-IR, and PBG was with statistically significant differences in hyperglycemia patients(P < 0.05).However,gender,age,PRL,The size of the tumor volume,HOMA-β,0'INS,120'INS,0'C-P,120'C-P,IGF-1 and HbA1c were with statistically significant differences(P > 0.05)compared with control group.In the study, The risk factors associated with hyperglycemia in GHPA were the course of the disease, BMI, GH, and FPG.In the study group, FPG was positively correlated with the size of the tumor volume and GH.PBG was positively correlated with FPG and HOMA-IR and negatively correlated with HOMA-β.In the subgroup analysis of the study group, FPG was with statistically significant differences (P=0.049). The results showed that FPG between the microadenoma group and the giant adenoma group was with statistically significant differences (P=0.019). However, PBG wasn't with statistically significant differences (P=0.133).In the present study, when we performed correlation analysis of risk factors and GHR genotype polymorphisms, we found that d3/d3GHR was significantly associated with BMI compared to f1/d3GHR (P=0.049), and d3/d3GHR explained 29.44% of the variation in BMI values;d3/d3GHR had a lower BMI value of 4.83kg/ m2.d3/d3GHR was not significantly correlated with GH (P=0.965), FPG (P=0.625), and the course of disease (P=0.755) compared to f1/d3GHR.

References

  1. Mestron A,Webb SM,Astorga R,Benito P,Catala M,Gaztambide S,Gomez JM,Halperin I,Lucas-Morante T,Moreno B,Obiols G,de Pablos P,Paramo C,Pico A,Torres E,Varela C,Vazquez JA,Zamora J,Albareda M and Gilabert M,(2004).Epidemiology,clinical characteristics,outcome,morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia,REA).Eur J Endocrinol.151,4,439-446.DOI: https://doi.org/10.1530/eje.0.1510439.Google ScholarGoogle Scholar
  2. Moller N,Jorgensen JO,(2009).Effects of growth hormone on glucose,lipid,and protein metabolism in human subjects.Endocr Rev.30,2,152-177.DOI: https://doi.org/10.1210/er.2008-0027.Google ScholarGoogle Scholar
  3. He W, Yan L, Wang M, Li Q, He M, Ma Z, Ye Z, Zhang Q, Zhang Y, Qiao N, Lu Y, Ye H, Lu B, Shou X, Zhao Y, Li Y, Li S, Zhang Z, Shen M and Wang Y,(2019).Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases.Endocrine.63,1,27-35.DOI: https://doi.org/10.1007/s12020-018-1745-7.Google ScholarGoogle Scholar
  4. Yoshida N,Goto H,Suzuki H,Nagasawa K,Takeshita A,Okubo M,Miyakawa M,Mori Y,Fukuhara N,Nishioka H,Yamada S,Takeuchi Y,(2013).Ketoacidosis is the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute. Eur J Endocrinol.169,1,127-132.DOI: https://doi.org/10.1530/June-13-0060.Google ScholarGoogle ScholarCross RefCross Ref
  5. Filopanti M,Giavoli C,Grottoli S,Bianchi A,De Marinis L,Ghigo E,Spada A,(2011).The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions.J Endocrinol Invest.34,11,861-868.DOI: https://doi.org/10.1007/BF03346731.Google ScholarGoogle Scholar
  6. Guevara-Aguirre J,Guevara A,Palacios I,Perez M,Procel P and Teran E,(2018).GH and GHR signaling in human disease.Growth Horm IGF Res.38,34-38.DOI: https://doi.org/10.1016/j.ghir.2017.12.006.Google ScholarGoogle Scholar
  7. Dutta P,Hajela A,Gupta P,Rai A,Sachdeva N,Mukherjee KK,Pathak A and Dhandapani S,(2019).The predictors of recovery from diabetes mellitus following neurosurgical treatment of acromegaly: A prospective study over a decade.Neurol India.27,3,757-762.DOI: https://doi.org/10.4103/0028-3886.263242.Google ScholarGoogle Scholar
  8. Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P and Maiter D,(2014).Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.Pituitary.17,1,81-89.DOI: https://doi.org/10.1007/s11102-013-0471-7.Google ScholarGoogle Scholar
  9. Gortan Cappellari G,Zanetti M,Semolic A,Vinci P,Ruozi G,Falcione A,Filigheddu N,Guarnieri G,Graziani A,Giacca M and Barazzoni R,(2016).Unacylated Ghrelin Reduces Skeletal Muscle Reactive Oxygen Species Generation and Inflammation and Prevents High-Fat Diet-Induced Hyperglycemia and Whole-Body Insulin Resistance in Rodents.Diabetes.65,4,874-886.DOI: https://doi.org/10.2337/db15-1019.Google ScholarGoogle Scholar
  10. Stratton IM,Adler AI,Neil HA,Matthews DR,Manley SE,Cull CA,Hadden D,Turner RC and Holman RR,(2000).Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.BMJ.321,7258,405-412.DOI: https://doi.org/10.1136/bmj.321.7258.405.Google ScholarGoogle Scholar
  11. Sorkin JD,Muller DC,Fleg JL and Andres R,(2005).The relation of fasting and 2-h post-challenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature.Diabetes Care.28,11,2626-2632.DOI: https://doi.org/10.2337/diacare.28.11.2626.Google ScholarGoogle Scholar
  12. Monnier l, Lapinski H and Colette C,(2003).Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c.Diabetes Care.26,3,881-885.DOI: https://doi.org/10.2337/diacare.26.3.881.Google ScholarGoogle Scholar
  13. Gonzalez B,Vargas G,de Los Monteros ALE,Mendoza V and Mercado M,(2018).Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly.J Clin Endocrinol Metab.103,6,2369-2375.DOI: https://doi.org/10.1210/jc.2018-00325.Google ScholarGoogle Scholar
  14. Gonzalez B,Vargas G,de Los Monteros ALE,Mendoza V,Mercado M,(2018).Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly.J Clin Endocrinol Metab.103,6,2369-2375..DOI: https://doi.org/10.1210/jc.2018-00325.Google ScholarGoogle Scholar
  15. Dos Santos C,Essioux L,Teinturier C,Tauber M,Goffin V and Bougneres P,(2004).A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone.Nat Genet.36,7,720-724.DOI: https://doi.org/10.1038/ng1379.Google ScholarGoogle Scholar
  16. Park HY,Hwang IR,Seo JB,Kim SW,Seo HA,Lee IK and Kim JG,(2015).Association between the Growth Hormone Receptor Exon 3 Polymorphism and Metabolic Factors in Korean Patients with Acromegaly.Endocrinol Metab (Seoul).30,3,312-317.DOI: https://doi.org/10.3803/EnM.2015.30.3.312.Google ScholarGoogle Scholar
  17. Montefusco L,Filopanti M,Ronchi CL,Olgiati L,La-Porta C,Losa M,Epaminonda P,Coletti F,Beck-Peccoz P,Spada A,Lania AG and Arosio M,(2010).d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.Clin Endocrinol (Oxf).72,5,661-667.DOI: https://doi.org/10.1111/j.1365-2265.2009.03703.x.Google ScholarGoogle Scholar
  18. Mercado M,González B,Sandoval C,Esquenazi Y,Mier F,Vargas G,de los Monteros AL and Sosa E,(2008).Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly.J Clin Endocrinol Metab.93,9,3411-3415.DOI: https://doi.org/10.1210/jc.2008-0391.Google ScholarGoogle Scholar
  1. Analysis of Risk Factors for Hyperglycemia and GHR Gene Polymorphism in Growth Hormone secreting Pituitary Adenoma

    Recommendations

    Comments

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Sign in
    • Published in

      cover image ACM Other conferences
      BIBE2021: The Fifth International Conference on Biological Information and Biomedical Engineering
      July 2021
      231 pages
      ISBN:9781450389297
      DOI:10.1145/3469678

      Copyright © 2021 ACM

      Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]

      Publisher

      Association for Computing Machinery

      New York, NY, United States

      Publication History

      • Published: 28 July 2021

      Permissions

      Request permissions about this article.

      Request Permissions

      Check for updates

      Qualifiers

      • research-article
      • Research
      • Refereed limited

      Acceptance Rates

      Overall Acceptance Rate36of116submissions,31%
    • Article Metrics

      • Downloads (Last 12 months)4
      • Downloads (Last 6 weeks)0

      Other Metrics

    PDF Format

    View or Download as a PDF file.

    PDF

    eReader

    View online with eReader.

    eReader

    HTML Format

    View this article in HTML Format .

    View HTML Format